Clarivate Appoints New CFO, Dr. Marcé Moore
Ticker: CLVT · Form: 8-K · Filed: Jul 24, 2024 · CIK: 1764046
| Field | Detail |
|---|---|
| Company | Clarivate PLC (CLVT) |
| Form Type | 8-K |
| Filed Date | Jul 24, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, cfo-appointment
TL;DR
Clarivate just hired a new CFO, Dr. Marcé Moore, replacing Ashley Johnson.
AI Summary
Clarivate Plc announced on July 24, 2024, that its Board of Directors has appointed Dr. Marcé Moore as Chief Financial Officer, effective July 23, 2024. Dr. Moore will also serve as a member of the company's executive leadership team. This appointment follows the departure of Ashley Johnson from the CFO role.
Why It Matters
The appointment of a new Chief Financial Officer is a significant leadership change that can impact investor confidence and the company's financial strategy.
Risk Assessment
Risk Level: medium — A change in CFO can signal underlying financial issues or strategic shifts, requiring closer monitoring.
Key Players & Entities
- Clarivate Plc (company) — Registrant
- Dr. Marcé Moore (person) — Appointed Chief Financial Officer
- Ashley Johnson (person) — Departing Chief Financial Officer
- July 24, 2024 (date) — Date of Report
- July 23, 2024 (date) — Effective date of appointment
FAQ
Who has been appointed as the new Chief Financial Officer of Clarivate Plc?
Dr. Marcé Moore has been appointed as the new Chief Financial Officer of Clarivate Plc.
When is the appointment of Dr. Marcé Moore effective?
The appointment of Dr. Marcé Moore is effective July 23, 2024.
Who is Dr. Marcé Moore replacing as CFO?
Dr. Marcé Moore is replacing Ashley Johnson as CFO.
What other role will Dr. Marcé Moore hold at Clarivate Plc?
Dr. Marcé Moore will also serve as a member of the company's executive leadership team.
What is the filing date of this Form 8-K?
The filing date of this Form 8-K is July 24, 2024.
Filing Stats: 478 words · 2 min read · ~2 pages · Grade level 11.4 · Accepted 2024-07-24 16:58:56
Filing Documents
- tm2420035d1_8k.htm (8-K) — 25KB
- tm2420035d1_ex99-1.htm (EX-99.1) — 8KB
- 0001104659-24-082366.txt ( ) — 203KB
- clvt-20240723.xsd (EX-101.SCH) — 3KB
- clvt-20240723_lab.xml (EX-101.LAB) — 33KB
- clvt-20240723_pre.xml (EX-101.PRE) — 22KB
- tm2420035d1_8k_htm.xml (XML) — 3KB
02 Departure of Directors or Principal
Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers. On July 23, 2024, Richard Roedel notified Clarivate Plc (the "Company") of his retirement from the Board of Directors of the Company, effective as of December 31, 2024. Mr. Roedel confirmed that his decision to retire is due to health reasons and not as a result of any disagreement between him and the Company, its management, the Board of Directors, or any committee thereof. The Company's press release dated July 24, 2024 announcing this change is attached hereto as Exhibit 99.1.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits (d) Exhibits No. Description 99.1 Press release issued by Clarivate Plc dated July 24, 2024 104 Cover page of this Current Report on Form 8-K formatted in Inline XBRL SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. CLARIVATE PLC Date: July 24, 2024 By: /s/ Melanie D. Margolin Name: Melanie D. Margolin Title: Executive Vice President, Chief Administrative and Legal Officer